Search for: "CIPLA"
Results 41 - 60
of 202
Sorted by Relevance
|
Sort by Date
3 May 2017, 8:07 am
Congratulations to CIPLA for hosting an exciting and informational event! [read post]
3 May 2017, 8:07 am
Congratulations to CIPLA for hosting an exciting and informational event! [read post]
19 Aug 2010, 12:12 pm
Earlier this month, the Swiss Multinational Novartis lost DULERA post-grant opposition to Mumbai-based Cipla as the Chennai Patent Office revoked Indian Patent Number 202350 on the ground of obviousness/lack of inventive step. [read post]
5 Sep 2007, 8:38 pm
Noonan -- The Federal Circuit today affirmed a District Court finding that ANDA filer Ivax Pharmaceuticals and co-Defendant Cipla had not shown by clear and convincing evidence that Forest Laboratories' patent-in-suit for Lexapro ® was invalid. [read post]
15 Jun 2014, 11:30 pm
As nosy as he is, this Leo went further to validate the point made by Cipla in that article by MIP. [read post]
23 Apr 2010, 9:57 am
The Ecuador CL is a tiered royalty bearing license.Scanned documents pertaining to Cipla's CL are available, here. [read post]
4 Jun 2012, 3:00 am
CIPLA Ltd., et al., Nos. 2011-1471, 1472 (Fed. [read post]
8 Feb 2010, 12:52 pm
Manish Rajan of livemint.com reported that the Delhi High Court on Monday dismissed the petition filed by Global Biopharma major UCB Frachim against the Indian generic major Cipla and the Indian Patent Office over rejection of its patent for a new anti-allergic drug. [read post]
16 Aug 2010, 5:42 am
Friends,On my track of the IPO publishing new decisions, I have found interesting reads in 2 new post grant opposition decisions.The first decision is for a proceeding between Richter and Cipla for contraceptive drugs. [read post]
14 Feb 2013, 4:28 pm
Cipla then filed an appeal in the Supreme Court against the High court decision. [read post]
8 Mar 2013, 2:45 am
CIPLA is an alleged infringer of the drug Nexavar. [read post]
9 May 2007, 10:07 am
The Brazilian government's decision to override the patent rights of Merck's HIV/AIDS drug Stocrin (efavirenz) and buy reverse engineered generic versions of the drug at low cost has come as a boon for Indian pharmaceutical companies manufacturing generic versions of efavirenz such as Cipla, Ranbaxy, Aurobindo Pharma and Strides Arcolab. [read post]
8 Jan 2011, 2:18 pm
The Application was refused after Bayer failed to overcome the pre-grant oppositions filed against the Application by generic manufacturers Cipla [read post]
19 Aug 2010, 12:12 pm
Earlier this month, the Swiss Multinational Novartis lost DULERA post-grant opposition to Mumbai-based Cipla as the Chennai Patent Office revoked Indian Patent Number 202350 on the ground of obviousness/lack of inventive step. [read post]
29 Nov 2012, 12:30 pm
Continuing from the last post that discussed background of Tarceva patent and the single judge order rejecting Roche's application for interim injunction to restrain Cipla from manufacturing and selling generic product Erlocip, here we discuss appeal filed by Roche before the divisional bench at the Delhi High Court against the rejection order. [read post]
23 Mar 2008, 10:59 pm
We had earlier reported on the Delhi High Court's refusal of injunction against Cipla's sale in India, of the drug Erlotinib [Tarceva (R)] in the suit filed by Roche.Natco had earlier challenged the Indian patent application for this drug in a pre-grant opposition proceeding, without success and then had applied for a Compulsory License to export this drug to Nepal.Now, the Economic Times reports [read post]
29 Nov 2012, 12:30 pm
Continuing from the last post that discussed background of Tarceva patent and the single judge order rejecting Roche's application for interim injunction to restrain Cipla from manufacturing and selling generic product Erlocip, here we discuss appeal filed by Roche before the divisional bench at the Delhi High Court against the rejection order. [read post]
2 Apr 2013, 8:30 am
It will be interesting to see whether the courts follow the Roche vs Cipla reasoning or have an entirely different take on this altogether.We will keep you posted! [read post]
30 Aug 2010, 6:19 am
Continued from our last post where we briefly discussed about the rejection of pre-grant opposition filed by Cipla for the Application Number 3003/CHENP/2004 for anti-cancer drug Nilotinib which later matured into issued Patent Number 237430. [read post]
30 Aug 2010, 6:19 am
Continued from our last post where we briefly discussed about the rejection of pre-grant opposition filed by Cipla for the Application Number 3003/CHENP/2004 for anti-cancer drug Nilotinib which later matured into issued Patent Number 237430. [read post]
